WHO PQ listing for Remdesivir

A SHORT BLOG: Questions are beginning to emerge as to why WHO proceeded to give a prequalification listing to Remdesivir, when it was aware of the results of its Solidarity Therapeutics trial on the drug’s lack of impact on the treatment for COVID-19. At the bi-weekly presser (on 16.10) last week, WHO’s top officials discussed briefly the independent processes of the prequalification process for Remdesivir (officially announced on the 15th) and the results of the Solidarity trial (highlighted on the 16th.)(See Soumya Swaminathan and Mariangela Simão address this question, half way into the briefing) It is also understood that the results from the Solidarity trial … Continue reading WHO PQ listing for Remdesivir

Reading the AstraZeneca-Oxford Trial. What’s at stake?

Given the scientific, economic, political, commercial and moral compulsions around vaccines for the pandemic, the adverse event in a clinical trial of a leading vaccine candidate has been a humbling moment for citizens, governments, companies and hopefully, politicians. The goal of this expert interview is to help us read the recent pause in a leading clinical trial (AZD1222) following a suspected adverse event and the subsequent news of the resumption of the trial in the UK. A lot has been published already on this trial, already in phase III, but a few aspects worth underscoring. First, that Pascal Soriot, CEO of … Continue reading Reading the AstraZeneca-Oxford Trial. What’s at stake?

Public health & tobacco plain packaging: Q&A with Benn McGrady, WHO

Q&A with Benn McGrady, Technical Officer (Legal), Public Health Law and Policies, Health Promotion (HPR) at World Health Organization. Geneva Health Files reached out to Benn McGrady, a health law expert. He speaks about what the recent WTO Appellate Body ruling on tobacco plain packaging, means for public health. McGrady an expert on the matter, is the author of the book Trade and Public Health: The WTO, Tobacco, Alcohol, and Diet , Cambridge: Cambridge University Press, 2011. The following are his responses to queries sent on email. 1. The significance of the ruling for public health and non-communicable diseases in … Continue reading Public health & tobacco plain packaging: Q&A with Benn McGrady, WHO